MIRUM PHARMACEUTICALS INC (MIRM)
NASDAQ • Healthcare
$100.87
+$1.04 (+1.0%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About MIRUM PHARMACEUTICALS INC
Name
MIRUM PHARMACEUTICALS INC
CEO
Christopher Peetz
Website
Industry
Healthcare
Year Founded
2018
Employees
418
Mirum Pharmaceuticals, Inc. develops and commercializes therapies for serious rare and orphan diseases as a biotechnology company listed on NASDAQ under MIRM. The business generated $521.3 million in FY2025 revenue, centered on liver-disease treatments and a pipeline aimed at several cholestatic conditions.
Fundamentals & Financials
Revenue (TTM)
$618M
Net Income (TTM)
-$860.2M
EPS (TTM)
-$14.55
ROA (TTM)
-82.32%
Current Ratio
2.86
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$100.87$99 - $101.26
52 Week RangeAvg. Volume$63.23 - $130749.7K
Market Cap$6.2B
Peers & Related Assets
PRAXPRAXIS PRECISION MEDICINES INC
$369.84-1.7%
TVTXTRAVERE THERAPEUTICS INC
$63.9+0.6%
LGNDLIGAND PHARMACEUTICALS INC
$287.59-1.4%
ACADACADIA PHARMACEUTICALS INC
$30.18+4.0%
DYNDYNE THERAPEUTICS INC
$26-0.6%
RAREULTRAGENYX PHARMACEUTICAL INC
$25.49-2.5%
ADMAADMA BIOLOGICS INC
$9.54+2.1%
BLTEBelite Bio, Inc
TLXTelix Pharmaceuticals Limited
SLNOSOLENO THERAPEUTICS INC